SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:152761615"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:152761615" > Definitions of non-...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Khaleva, E (author)

Definitions of non-response and response to biological therapy for severe asthma: a systematic review

  • Article/chapterEnglish2023

Publisher, publication year, extent ...

  • 2023-01-26
  • European Respiratory Society (ERS),2023

Numbers

  • LIBRIS-ID:oai:prod.swepub.kib.ki.se:152761615
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:152761615URI
  • https://doi.org/10.1183/23120541.00444-2022DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Biologics have proven efficacy for patients with severe asthma but there is lack of consensus on defining response. We systematically reviewed and appraised methodologically developed, defined, and evaluated definitions of non-response and response to biologics for severe asthma.MethodsWe searched four bibliographic databases from inception to 15th March 2021 (PROSPERO: CRD42021211249).Two reviewers screened references, extracted data, assessed methodological quality of development, measurement properties of outcome measures and definitions of response based on COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN). Modified GRADE approach and narrative synthesis were undertaken.ResultsThirteen studies reported three composite outcome measures, three measures of asthma symptoms, one asthma control and one quality of life. Only four were developed with patient input; none were composite measures. Studies utilised 17 definitions of response: 10/17 (58.8%) were based on Minimal Clinically Important Difference (MCID) or Minimal Important Difference (MID) and 16/17 (94.1%) had high quality evidence. Results were limited by poor methodology for development process and incomplete reporting of psychometric properties. Most measures rated “very low” to “low” for quality of measurement properties and none met all quality standards.ConclusionThis is the first review to synthesize evidence about definitions of response to biologics for severe asthma. While high quality definitions are available, most are MCIDs or MIDs which may be insufficient to justify continuation of biologics in terms of cost-effectiveness. There remains an unmet need for universally accepted, patient-centred, composite definitions to aid clinical decision making and comparability of responses to biologics.

Added entries (persons, corporate bodies, meetings, titles ...)

  • Rattu, A (author)
  • Brightling, C (author)
  • Bush, A (author)
  • Bourdin, A (author)
  • Bossios, AKarolinska Institutet (author)
  • Chung, KF (author)
  • Chaudhuri, R (author)
  • Coleman, C (author)
  • Djukanovic, R (author)
  • Dahlen, SEKarolinska Institutet (author)
  • Exley, A (author)
  • Fleming, L (author)
  • Fowler, SJ (author)
  • Gupta, A (author)
  • Hamelmann, E (author)
  • Koppelman, GH (author)
  • Melen, EKarolinska Institutet (author)
  • Mahler, V (author)
  • Seddon, P (author)
  • Singer, F (author)
  • Porsbjerg, C (author)
  • Ramiconi, V (author)
  • Rusconi, F (author)
  • Yasinska, VKarolinska Institutet (author)
  • Roberts, G (author)
  • Karolinska Institutet (creator_code:org_t)

Related titles

  • In:ERJ open research: European Respiratory Society (ERS)9:32312-0541

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view